Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes
- PMID: 8445992
- DOI: 10.1016/0024-3205(93)90194-8
Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes
Abstract
We determined the uptake blockade produced by eight new antidepressant drugs (etoperidone, femoxetine, lofepramine, nefazodone, paroxetine, sertraline, tomoxetine, and venlafaxine), two metabolites of newer antidepressants (desmethylsertraline and norfluoxetine), seven previously reported antidepressants, and carbamazepine. Inhibitor constants (Kis) for uptake blockade were obtained from competitive uptake studies with [3H]norepinephrine, [3H]5-hydroxytryptamine, and [3H]dopamine in rat brain synaptosomes prepared from hippocampus, frontal cortex, and striatum, respectively. Among the newer compounds, tomoxetine (Ki = 0.7 nM) and lofepramine (Ki = 1.9 nM) were potent and selective [3H]norepinephrine uptake blockers; paroxetine (Ki = 0.73 nM), sertraline (Ki = 3.4 nM), and femoxetine (Ki = 22 nM) potently and selectively inhibited [3H]5-hydroxytryptamine uptake. Although none of the drugs was potent for [3H]dopamine uptake blockade, sertraline was the most potent (Ki = 260 nM). These data are useful in predicting adverse effects and drug-drug interactions of antidepressants.
Similar articles
-
Blockade by antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes: most antidepressants selectively block norepinephrine uptake.Eur J Pharmacol. 1984 Sep 17;104(3-4):277-86. doi: 10.1016/0014-2999(84)90403-5. Eur J Pharmacol. 1984. PMID: 6499924
-
Inhibition of in vitro amine uptake into rat brain synaptosomes after in vivo administration of antidepressants.Eur J Pharmacol. 1983 Nov 25;95(3-4):305-9. doi: 10.1016/0014-2999(83)90652-0. Eur J Pharmacol. 1983. PMID: 6653676
-
Preclinical evaluation of McN-5707 as a potential antidepressant.J Pharmacol Exp Ther. 1987 Jul;242(1):74-84. J Pharmacol Exp Ther. 1987. PMID: 3039115
-
Effects of clomipramine and other tricyclic antidepressants on biogenic amine uptake and turnover.Postgrad Med J. 1976;52(3 suppl):33-9. Postgrad Med J. 1976. PMID: 785423 Review. No abstract available.
-
The interactions of tricyclic antidepressants with the biogenic amine uptake systems in the central nervous system.Postgrad Med J. 1976;52(3 suppl):25-32. Postgrad Med J. 1976. PMID: 785422 Review. No abstract available.
Cited by
-
Atomoxetine: a review of its use in adults with attention deficit hyperactivity disorder.Drugs. 2004;64(2):205-22. doi: 10.2165/00003495-200464020-00005. Drugs. 2004. PMID: 14717619 Review.
-
Clinically relevant pharmacology of selective serotonin reuptake inhibitors. An overview with emphasis on pharmacokinetics and effects on oxidative drug metabolism.Clin Pharmacokinet. 1997;32 Suppl 1:1-21. doi: 10.2165/00003088-199700321-00003. Clin Pharmacokinet. 1997. PMID: 9068931 Review.
-
Antidepressant-like activity of adhyperforin, a novel constituent of Hypericum perforatum L.Sci Rep. 2014 Jul 9;4:5632. doi: 10.1038/srep05632. Sci Rep. 2014. PMID: 25005489 Free PMC article.
-
The efficacy of atomoxetine for the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a comprehensive review of over a decade of clinical research.CNS Drugs. 2015 Feb;29(2):131-51. doi: 10.1007/s40263-014-0224-9. CNS Drugs. 2015. PMID: 25698145 Review.
-
Dissociations between cognitive and motor effects of psychostimulants and atomoxetine in hyperactive DAT-KO mice.Psychopharmacology (Berl). 2014 Jan;231(1):109-22. doi: 10.1007/s00213-013-3212-8. Epub 2013 Aug 3. Psychopharmacology (Berl). 2014. PMID: 23912772
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical